Allogene Therapeutics, Inc. (ALLO)

NASDAQ: ALLO · Real-Time Price · USD

2.190

-0.060 (-2.67%)

At close: Apr 28, 2026, 4:00 PM EDT

2.190

0.00 (0.00%)

After-hours: Apr 28, 2026, 4:06 PM EDT

Allogene Therapeutics Market Cap

Allogene Therapeutics has a market cap or net worth of $751.59 million as of April 28, 2026. Its market cap has increased by 152.51% in one year.

Market Cap

751.59M

Enterprise Value

594.95M

1-Year Change

152.51%

Ranking

#2766

Market Cap Chart

Since October 11, 2018, Allogene Therapeutics's market cap has decreased from $2.88B to $751.59M, a decrease of -73.91%. That is a compound annual growth rate of -16.31%.

Market Cap History

Date	Market Cap	% Change
Apr 27, 2026	773.95M	151.38%
Dec 31, 2025	307.88M	-31.06%
Dec 31, 2024	446.60M	-17.32%
Dec 29, 2023	540.17M	-40.45%
Dec 30, 2022	907.08M	-57.34%
Dec 31, 2021	2.13B	-39.95%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
MannKind	833.75M
Arbutus Biopharma	827.15M
Crescent Biopharma	823.70M
ARS Pharmaceuticals	823.17M
Kura Oncology	821.94M
SELLAS Life Sciences Group	800.94M
Cullinan Therapeutics	800.16M
SpyGlass Pharma	786.19M

Market Cap Rankings